Catalent
CTLT
#1825
Rank
โ‚น1.083 T
Marketcap
โ‚น5,969
Share price
0.00%
Change (1 day)
20.94%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น595.23. In 2023 the company made an earnings per share (EPS) of -โ‚น639.42 a decrease over its 2022 EPS that were of โ‚น213.45.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-17.56%
2023-โ‚น639.42-399.56%
2022โ‚น213.45-30.58%
2021โ‚น307.4979.67%
2020โ‚น171.14114.12%
2019โ‚น79.93-15%
2018โ‚น94.0375.44%
2017โ‚น53.60-22.97%
2016โ‚น69.58-59.56%
2015โ‚น172.08282.05%
2014โ‚น45.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น71.47-87.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น341.34-157.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น70.52-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น139.17-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA